Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes

PURPOSE: To assess the effect of acarbose in lowering low-grade albuminuria compared to metformin in newly diagnosed Chinese type 2 diabetes (T2DM) patients. PATIENTS AND METHODS: The Metformin and AcaRbose Clinical Trial was a randomized, open-label trial in newly diagnosed T2DM patients. Participa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lulu, Kong, Xiaomu, Yang, Zhaojun, Zhang, Jinping, Yang, Wenying, Zhang, Bo, Chen, Xiaoping, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577516/
https://www.ncbi.nlm.nih.gov/pubmed/34764663
http://dx.doi.org/10.2147/DMSO.S325683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577516/
https://www.ncbi.nlm.nih.gov/pubmed/34764663
http://dx.doi.org/10.2147/DMSO.S325683

Ejemplares similares